
Keywords: نوع 2 التهاب; Asthma; type 2 inflammation; phenotypes; airway mucosal gene expression; biomarkers; ADEPT; Airways Disease Endotyping for Personalized Therapeutics; bEOS; Blood eosinophil; CLCA1; Calcium-activated chloride channel regulator 1; FDR; False discovery rate;